Antileukemic Potential of Momordica charantia Seed Extracts on Human Myeloid Leukemic HL60 Cells
Momordica charantia (bitter gourd) has been used in the traditional system of medicine for the treatment of various diseases. Anticancer activity of M. charantia extracts has been demonstrated by numerous in vitro and in vivo studies. In the present study, we investigated the differentiation inducin...
Main Authors: | Ramani Soundararajan, Punit Prabha, Umesh Rai, Aparna Dixit |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2012/732404 |
Similar Items
-
Comprehensive Evaluation of Anti-hyperglycemic Activity of Fractionated Momordica charantia Seed Extract in Alloxan-Induced Diabetic Rats
by: Shailesh Kumar Choudhary, et al.
Published: (2012-01-01) -
Evaluation of phytochemical and pharmacological properties of seeds of Momordica charantia
by: Sumyya Zahan, et al.
Published: (2020-09-01) -
The Bioactive Evaluation of the Extract Vines of Momordica Charantia
by: LI,JIA-PEI, et al.
Published: (2019) -
Activation of PKC-e counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members
by: A. Gonelli, et al.
Published: (2009-09-01) -
Activation of PKC-e counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members
by: C. Celeghini, et al.
Published: (2009-09-01)